| payload |
{"created_at":"2026-04-03T21:00:09.276 {"created_at":"2026-04-03T21:00:09.276432+00:00","dedupe_key":"opportunity_case_memory:case_61f98d71eaf9126f:monitor:2026-04-03T21","evidence_event_ids":["evt_7263e1b4491f","evt_cedc12988e9c","evt_7705a69439bd","evt_439036825987"],"reason_trace":{"case_id":"case_61f98d71eaf9126f","decision":"monitor","entity_key":"equity:TVTX","memory_only":true,"theme_key":"entity_development"},"severity":"low","signal_type":"opportunity_case_memory","source":"opportunity_finder","throttle_s":3600,"value":{"case_id":"case_61f98d71eaf9126f","confidence":0.42,"corroboration":{"agreement":{"count_score":1.0,"down_count":0,"magnitude_weighted_score":1.0,"majority_direction":"up","neutral_count":2,"score":1.0,"up_count":2},"base_score":0.7611,"claim_graph":{"case_signal_families":["technical","filing"],"case_source_domains":["sec.gov"],"claims":[{"agreement_score":0.6,"claim_id":"claim_65556c9836e8948b","conflict":false,"direction":"neutral","evidence_count":2,"family_coverage":1,"quality_score":0.4803,"source_coverage":1,"source_trust":0.97,"statement":"Eric M. Dube, CEO of Travere Therapeutics, sold shares of common stock and exercised stock options as reported in Form 4.","strength":0.6211},{"agreement_score":1.0,"claim_id":"claim_9978eb33c3a28771","conflict":false,"direction":"up","evidence_count":2,"family_coverage":1,"quality_score":0.39,"source_coverage":0,"source_trust":0.0,"statement":"TVTX technical emaCrossUp","strength":0.4458}],"coverage":{"claim_count":2,"conflicting_claims":0,"dominant_claim_id":"claim_65556c9836e8948b","multi_family_claims":0,"multi_source_claims":0},"score":0.3341},"contradiction":{"flags":[],"has_unresolved_conflict":false,"resolved_claims":[],"resolved_count":0,"score":0.0,"unresolved_claims":[],"unresolved_count":0},"contradiction_flags":["thin_independent_source_coverage"],"evidence_event_count":4,"high_precision_pass":false,"high_trust_source_coverage":1,"independent_source_coverage":1,"low_trust_source_coverage":0,"score":0.6314,"signal_family_coverage":2,"source_trust":{"avg_score":0.715,"domains":[{"count":2,"domain":"sec.gov","score":0.97,"source":"sec_edgar"},{"count":2,"domain":"","score":0.46,"source":"technical_analyzer"}],"high_trust_domains":["sec.gov"],"independent_high_trust_sources":1,"low_trust_domains":[]},"source_trust_score":0.8055},"decision":"monitor","entity_key":"equity:TVTX","evidence_event_count":4,"headline":"Eric M. Dube, CEO of Travere Therapeutics, sold shares of common stock and exercised stock options as reported in Form 4.","personal_relevance_score":0.1,"theme_key":"entity_development","why_now":"Signal convergence: Eric M. Dube, CEO of Travere Therapeutics, sold shares of common stock and exercised stock options as reported in Form 4. [neutral]; TVTX technical emaCrossUp [up]"}}... |